Premium
Docosahexaenoic acid downregulates phenobarbital‐induced cytochrome P450 2B1 gene expression in rat primary hepatocytes via the c‐Jun NH2‐terminal kinase mitogen‐activated protein kinase pathway
Author(s) -
Lu ChiaYang,
Li ChienChun,
Liu KaiLi,
Lii ChongKuei,
Chen HawWen
Publication year - 2009
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.200800112
Subject(s) - mapk/erk pathway , protein kinase a , phenobarbital , kinase , biology , constitutive androstane receptor , p38 mitogen activated protein kinases , cytochrome p450 , microbiology and biotechnology , chemistry , biochemistry , pharmacology , enzyme , nuclear receptor , transcription factor , gene
Mitogen‐activated protein kinase (MAPK) pathways play central roles in the transduction of extracellular stimuli into cells and the regulation of expression of numerous genes. Docosahexaenoic acid (DHA) was shown to be involved in the regulation of expression of drug metabolizing enzymes (DMEs) in rat primary hepatocytes in response to xenobiotics. Cytochrome P450 2B1 (CYP 2B1) is a DME that is dramatically induced by phenobarbital‐type inducers. The constitutive androstane receptor (CAR) plays a critical role in regulating the expression of DMEs, and the phosphorylation/dephosphorylation of CAR is an important event in CYP 2B1 expression. In the present study, we determined the effect of DHA on MAPK transactivation and its role in CYP 2B1 expression induced by phenobarbital. c‐Jun NH2‐terminal kinase (JNK) JNK1/2 and ERK1/2 were activated by phenobarbital in a dose‐dependent manner. DHA (100 μM) inhibited JNK1/2 and ERK2 activation induced by phenobarbital in a time‐dependent manner. Both SP600125 (a JNK inhibitor) and SB203580 (a p38 MAPK inhibitor) inhibited CYP 2B1 protein and mRNA expression induced by phenobarbital. SB203580 significantly increased the intracellular 3′‐5′‐cyclic adenosine monophosphate (cAMP) concentration compared with a control group ( p < 0.05). Our results suggest that inhibition of JNK activation by DHA is at least part of the mechanisms of DHA's downregulation of CYP 2B1 expression induced by phenobarbital.